News Release

Study finds risk disparity for Black children who have stroke after heart transplant

Journal of the American Heart Association Report

Peer-Reviewed Publication

American Heart Association

DALLAS, JULY 13, 2022 – Black children who underwent heart transplant surgery for the first time were more than three times as likely to die after six months than white children, according to new research published today in the Journal of the American Heart Association.

The study’s authors found that, within six months after receiving a heart transplant, Black children who had a stroke had a similar death rate compared with white children who had a stroke. However, after six months, Black children who had a stroke were more than three times as likely to die as white children. (Downloadable graphic/transcript available on the right column of the release link under additional resources.)

The authors analyzed data about 8,224 children who received cardiac transplants from January 1994 through September 2019. The data came from the Scientific Registry of Transplant Recipients (SRTR), a national database of all organ transplants in the United States. The researchers adjusted their analyses for factors including age, sex, cognitive difficulties, insurance status, transplant year and the reason for heart transplant.

The authors found that Black children had a 32% lower chance of experiencing a stroke after a heart transplant compared to white children. However, they noted that in a recent study using the SRTR database, Black children had a 25% higher mortality rate while on the transplant waitlist compared to white children, suggesting that Black children who are at a higher risk of experiencing a stroke may be less likely to survive to receive a heart transplant.

Citation: Laura Lehman, et. al. Racial Disparities in Incidence and Prognosis of Perioperative Stroke among Pediatric Cardiac Transplant Recipients. Journal of the American Heart Association. July 13, 2022. doi/10.1161/JAHA.121.025149.

Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here

Additional Resources:

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.orgFacebookTwitter or by calling 1-800-AHA-USA1.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.